Reva Medical ramps up production of bioresorbable scaffold


Reva Medical (San Diego, CA) is ramping up manufacturing capacity to produce its proprietary bioresorbable polymer scaffolds as it scales up testing in anticipation of commercialization in 2014.

The company also announced that it has developed a new compound that allows for smaller and stronger scaffolds to treat more distant coronary arterial lesions that can lead to heart failure.

The new material contains 85% the same materials as the original compound used in its ReZolve scaffolds and does not need to be requalified, Robert B. Stockman, cofounder and CEO said in a conference call with investment analysts to discuss second quarter results. Reva Medical calls ReZolve a scaffold because it is not a permanent device like a stent, which is made from metal....
Read more